Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07849465) titled 'Hyperbaric Oxygen Therapy for Veterans With TBI and PCS: A Biomarker Study' on Sept. 24.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Summit Hyperbarics and Wellness
Condition:
Traumatic Brain Injury (TBI) Patients
Post Concussive Symptoms
PTSD
Intervention:
Drug: Hyperbaric Oxygen Therapy (HBOT)
Recruitment Status: Recruiting
Phase: Phase 2
Date of First Enrollment: October 1, 2026
Target Sample Size: 34
Countries of Recruitment:
United States
To know more, visit https://c...